Clinical Trial Update: Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating pulsatile intravenous insulin therapy for Type 1 and Type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (pulsatile IV infusion protocol) (insulin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Diabetes Mellitus | Phase 2, Phase 3 | Status: TERMINATED